LIP
Liontrust Investment Partners’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $189M | Sell |
466,462
-23,928
| -5% | -$9.7M | 2.71% | 6 |
|
|
2025
Q1 | $244M | Buy |
490,390
+1,693
| +0.3% | +$842K | 3.81% | 2 |
|
|
2024
Q4 | $254M | Buy |
488,697
+81,911
| +20% | +$42.6M | 3.69% | 2 |
|
|
2024
Q3 | $225M | Hold |
406,786
| – | – | 3.2% | 5 |
|
|
2024
Q2 | $225M | Sell |
406,786
-11,534
| -3% | -$6.38M | 3.2% | 5 |
|
|
2024
Q1 | $243M | Sell |
418,320
-41,134
| -9% | -$23.9M | 3.39% | 3 |
|
|
2023
Q4 | $244M | Buy |
459,454
+50,260
| +12% | +$26.7M | 3.54% | 3 |
|
|
2023
Q3 | $207M | Buy |
409,194
+14,132
| +4% | +$7.15M | 3.31% | 5 |
|
|
2023
Q2 | $206M | Buy |
395,062
+20,824
| +6% | +$10.9M | 2.97% | 7 |
|
|
2023
Q1 | $216M | Buy |
374,238
+27,324
| +8% | +$15.7M | 3.16% | 4 |
|
|
2022
Q4 | $191M | Sell |
346,914
-29,900
| -8% | -$16.5M | 3.34% | 5 |
|
|
2022
Q3 | $191M | Sell |
376,814
-64,800
| -15% | -$32.9M | 3.06% | 5 |
|
|
2022
Q2 | $240M | Sell |
441,614
-53,800
| -11% | -$29.2M | 3.38% | 6 |
|
|
2022
Q1 | $293M | Buy |
495,414
+4,500
| +0.9% | +$2.66M | 3.82% | 3 |
|
|
2021
Q4 | $328M | Sell |
490,914
-54,700
| -10% | -$36.5M | 3.9% | 3 |
|
|
2021
Q3 | $312M | Buy |
+545,614
| New | +$312M | 4.31% | 3 |
|
|
2020
Q4 | $148M | Buy |
+317,514
| New | +$148M | 2.98% | 8 |
|